Diabetic retinopathy (DR) is one of the major causes of blindness in the United States. The risk of DR is directly related to the degree and duration of hyperglycemia. Several clinical studies have identified which modes of therapy are effective in treating DR, who is at highest risk, and who will benefit the most from intervention. Six of those studies are summarized here.
Click on the highlighted citations for summaries of studies
The Wisconsin Epidemiologic Study
Diabetes Control and Complications Trial Research Group
Early Treatment Diabetic Retinopathy Study Research Group
The Diabetic Retinopathy Study Research Group
Diabetic Retinopathy Vitrectomy Study Research Group
UK Prospective Diabetes Study
This web resource is made possible through an unrestricted educational grant from Eli Lilly and Company.
|
